Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

In vitro 3D full-thickness skin-equivalent tissue model using silk and collagen biomaterials.

Bellas E., Seiberg M., Garlick J., Kaplan DL.

Laboratory Study, published in Macromol Biosci (2012) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Macromol Biosci (2012)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
23161763
PMCID
PMC3724336
DOI
10.1002/mabi.201200262
Citations
95

Abstract (original English)

Current approaches to skin equivalents often only include the epidermis and dermis. Here, a full-thickness skin equivalent is described including epidermis, dermis, and hypodermis, that could serve as an in vitro model for studying skin biology or as a platform for consumer product testing. The construct is easy to handle and is maintained for >14 d while expressing physiological morphologies of the epidermis and dermis, seen by keratin 10, collagens I and IV expression. The skin equivalent produces glycerol and leptin, markers of adipose metabolism. This work serves as a foundation for understanding a few necessary factors needed to develop a stable, functional model of full-thickness skin.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimal Testing AlternativesCollagenDNA PrimersEnzyme-Linked Immunosorbent AssayFibroblastsGene Expression ProfilingHistological TechniquesHumansImmunohistochemistry

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.